
Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
Bristol Myers Squibb & Co BMY reported first-quarter 2025 revenues of $11.20 billion, beating the consensus of $10.70 billion. Sales decreased 6% year-over-year, or 4% when adjusted for foreign exchange impacts. U.S. revenues of $7.9 billion decreased …